1、 2014 2 2 016 5 128 , , , A , A 90.63% (58/64) , B 75% (48/64) ;A B ;A TC TG LDL-C B , HDL-C B , , ; ; ; ; , , , 1 2 , ( ) , , 1 1.1 2014 2 2016 5 128 : (1) 1995 ; (2) 2002 ; (3) , (2 24 ) ; (4) , 4070 ; (4) , : (1) ; (2) ; (3) , ; (4) TT PT APTT 1.5 , 150mg/L, ; (5) , A 64 , 41 , 23 , 3766 , , 15 ,
2、 ;B 64 , 33 , 31 , 3365 , , 0.56 , 7) (P0.05) 1 2 1.2 , B ( ;H62021159) , 100mg/ / (Lek Pharmaceuticals d.d, H20100053) , 20mg/ / A , 120g, 3g, 6g , 200ml, , , 2 : , , , 10 5min 14d 2d, 14d 1 , 4 1.3 TC TG HDL-C LDL-C; 35 (FIM) Rankin (MRS) 3 1.4 1995 2002 1.5 SPSS19.0 , , t ; (%) , X P0.05 2 2.1 A
3、FIM B , MRS A B , , 1 2.2 A ( + + ) 90.63% (58/64) , B 75% (48/64) , P0.05, 2.3 , A TC TG LDL-C B , HDL-C B , 2 3 , , , , ( ) ( ) , ( 75%) , , , , , 4 , , , , , , ; ; , ; , , , , , 5 6 , A 90.63% (58/64) , B 75% (48/64) ;A B ;A TC TG LDL-C B , HDL-C B , , 1 , , , . 30 J. , 2015, 13 (20) :3537 2 . 48 J. , 2012, 30 (2) :2830 3 , , . J. , 2016 (5) :9396 4 , , , . J. , 2015, 35 (3) :281286 5 . J. , 2014, 6 (5) :262265 6 , , , . PDGF J. , 2012, (1) :4041
